Pharmaceutical companies by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Takeda Pharmaceutical has the lowest figure of the 61 pharmaceutical companies ranked by short interest, at 0.10%, followed by AstraZeneca (0.20%) and Novartis (0.24%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- Takeda Pharmaceutical0.10%
- Median
- 5.47%
- Combined market value
- DKK 34.46T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Short interest % ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Takeda PharmaceuticalTAK · Health Care | 0.10% | DKK 463.2B | DKK 145.00 | 1.71% down | 54% up | ||
| 2 | AstraZenecaAZN · Health Care | 0.20% | DKK 1.89T | DKK 1,216.17 | 2.12% down | 2% up | ||
| 3 | NovartisNVS · Health Care | 0.24% | DKK 1.99T | DKK 1,055.53 | 2.70% down | 25% up | ||
| 4 | SanofiSNY · Health Care | 0.51% | DKK 772B | DKK 321.52 | 0.77% down | 4% down | ||
| 5 | Johnson & JohnsonJNJ · Health Care | 0.71% | DKK 4.48T | DKK 1,861.05 | 2.04% down | 38% up | ||
| 6 | GSKGSK · Health Care | 0.81% | DKK 664.2B | DKK 331.34 | 1.29% down | 6% up | ||
| 7 | Eli LillyLLY · Health Care | 0.81% | DKK 8.39T | DKK 9,415.18 | 2.43% down | 35% up | ||
| 8 | Novo NordiskNVO · Health Care | 0.87% | DKK 1.18T | DKK 268.52 | 3.22% down | 17% down | ||
| 9 | GrifolsGRFS · Health Care | 0.88% | DKK 39.1B | DKK 57.43 | 2.38% down | 1% up | ||
| 10 | AbbVieABBV · Health Care | 0.89% | DKK 3.44T | DKK 1,943.60 | 2.63% down | 26% up | ||
| 11 | Merck & CoMRK · Health Care | 1.08% | DKK 2.3T | DKK 934.94 | 4.34% down | 51% up | ||
| 12 | Abbott LaboratoriesABT · Health Care | 1.10% | DKK 1.23T | DKK 712.64 | 0.16% down | 17% down | ||
| 13 | BeOne MedicinesONC · Health Care | 1.40% | DKK 314.6B | DKK 2,754.37 | 2.23% down | 17% up | ||
| 14 | GenmabGMAB · Health Care | 1.57% | DKK 215.3B | DKK 349.23 | 1.40% down | 70% up | ||
| 15 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | DKK 928.4B | DKK 3,661.73 | 0.55% up | 27% up | ||
| 16 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | DKK 666.9B | DKK 6,446.27 | 1.27% down | 36% up | ||
| 17 | Royalty PharmaRPRX · Health Care | 2.27% | DKK 271.3B | DKK 471.90 | 0.79% up | 78% up | ||
| 18 | Bristol-Myers SquibbBMY · Health Care | 2.29% | DKK 829.9B | DKK 406.01 | 2.92% down | 34% up | ||
| 19 | PfizerPFE · Health Care | 2.36% | DKK 1.09T | DKK 191.32 | 1.42% down | 14% up | ||
| 20 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.38% | DKK 335.2B | DKK 287.26 | 1.13% down | 74% up | ||
| 21 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.03% | DKK 85.1B | DKK 102.12 | 1.29% up | 5% up | ||
| 22 | ViatrisVTRS · Health Care | 3.07% | DKK 160.9B | DKK 140.33 | 0.66% up | 96% up | ||
| 23 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | DKK 51.7B | DKK 148.37 | 3.05% up | 83% up | ||
| 24 | Belite BioBLTE · Health Care | 3.40% | DKK 43B | DKK 1,058.90 | 1.51% down | 31% up | ||
| 25 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | DKK 135.5B | DKK 1,011.97 | 5.14% down | 66% down | ||
| 26 | ZoetisZTS · Health Care | 4.12% | DKK 237.3B | DKK 584.14 | 2.65% up | 29% down | ||
| 27 | United TherapeuticsUTHR · Health Care | 4.31% | DKK 168.1B | DKK 3,946.13 | 0.89% down | 23% up | ||
| 28 | Ascendis PharmaASND · Health Care | 4.57% | DKK 120.7B | DKK 1,839.66 | 0.49% down | 28% up | ||
| 29 | ABIVAXABVX · Health Care | 4.70% | DKK 49.9B | DKK 569.48 | 1.75% up | 27% down | ||
| 30 | Summit TherapeuticsSMMT · Health Care | 5.28% | DKK 57.6B | DKK 72.02 | 0.98% down | 36% down | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 5.47% | DKK 50.9B | DKK 647.20 | 0.18% down | 126% up | ||
| 32 | Legend BiotechLEGN · Health Care | 6.13% | DKK 21.4B | DKK 110.43 | 0.56% up | 42% down | ||
| 33 | Axsome TherapeuticsAXSM · Health Care | 6.20% | DKK 48B | DKK 913.33 | 1.45% down | 7% down | ||
| 34 | Roivant SciencesROIV · Health Care | 6.28% | DKK 190.3B | DKK 262.59 | 0.49% down | 90% up | ||
| 35 | InsmedINSM · Health Care | 6.42% | DKK 179.8B | DKK 819.46 | 1.35% down | 40% down | ||
| 36 | Elanco Animal HealthELAN · Health Care | 6.59% | DKK 91.4B | DKK 182.90 | 3.79% up | 20% up | ||
| 37 | Definium TherapeuticsDFTX · Health Care | 7.02% | DKK 26.7B | DKK 195.27 | 2.50% down | 169% up | ||
| 38 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | DKK 80.8B | DKK 416.96 | 4.54% up | 11% up | ||
| 39 | VeradermicsMANE · Health Care | 8.03% | DKK 35.9B | DKK 850.20 | 0.73% down | 233% up | ||
| 40 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | DKK 41.8B | DKK 295.51 | 0.84% up | 10% up | ||
| 41 | Corcept TherapeuticsCORT · Health Care | 8.34% | DKK 50.7B | DKK 462.80 | 3.11% down | 8% down | ||
| 42 | Jazz PharmaceuticalsJAZZ · Health Care | 9.03% | DKK 107.6B | DKK 1,675.73 | 2.12% up | 37% up | ||
| 43 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | DKK 63.6B | DKK 2,736.88 | 4.86% down | 24% down | ||
| 44 | PTC TherapeuticsPTCT · Health Care | 9.31% | DKK 34.2B | DKK 409.49 | 0.48% down | 20% down | ||
| 45 | Oruka TherapeuticsORKA · Health Care | 9.53% | DKK 44.1B | DKK 649.72 | 1.05% down | 241% up | ||
| 46 | Travere TherapeuticsTVTX · Health Care | 9.96% | DKK 33.1B | DKK 344.46 | 1.12% down | 44% up | ||
| 47 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | DKK 41.1B | DKK 630.02 | 0.51% up | 31% up | ||
| 48 | Cogent BiosciencesCOGT · Health Care | 10.0% | DKK 33.3B | DKK 191.28 | 0.75% up | 20% down | ||
| 49 | ErascaERAS · Health Care | 10.6% | DKK 32.2B | DKK 91.79 | 3.06% down | 403% up | ||
| 50 | BridgeBio PharmaBBIO · Health Care | 10.7% | DKK 103.3B | DKK 530.29 | 1.29% up | 17% up | ||
| 51 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | DKK 30.9B | DKK 282.22 | 1.52% down | 88% up | ||
| 52 | AlkermesALKS · Health Care | 11.7% | DKK 53.2B | DKK 316.34 | 2.10% up | 58% up | ||
| 53 | Spyre TherapeuticsSYRE · Health Care | 12.2% | DKK 64.7B | DKK 681.14 | 6.51% up | 286% up | ||
| 54 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | DKK 40.8B | DKK 2,037.23 | 1.72% up | 43% up | ||
| 55 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | DKK 31.5B | DKK 189.10 | 2.89% up | 64% down | ||
| 56 | CytokineticsCYTK · Health Care | 12.9% | DKK 48.6B | DKK 349.23 | 0.81% down | 20% down | ||
| 57 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | DKK 58.2B | DKK 2,083.24 | 0.18% up | 61% up | ||
| 58 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | DKK 55.9B | DKK 855.74 | 0.69% up | 46% up | ||
| 59 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | DKK 32.8B | DKK 582.98 | 1.68% down | 113% up | ||
| 60 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | DKK 56.5B | DKK 814.35 | 2.44% up | 13% up | ||
| 61 | TG TherapeuticsTGTX · Health Care | 19.0% | DKK 67.5B | DKK 446.51 | 4.45% up | 107% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8169 DKK).
Questions and answers
Which pharmaceutical companies have the lowest short interest?
Takeda Pharmaceutical (0.10%), AstraZeneca (0.20%) and Novartis (0.24%) have the lowest short interest of the 61 pharmaceutical companies ranked here as of the 30 Oct 2026 settlement date.
How many pharmaceutical companies are in this ranking?
61 are ranked by short interest.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by short interest have a combined market value of DKK 34.46T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Pharmaceutical companies by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.